A 3-Month Open-Label Safety and Efficacy Study of TNX-102 SL Tablets in Fibromyalgia Patients
Trial details
- Registry ID
- NCT02589275
- Phase
- Phase 3
Drug identity checked against registry records
Also recorded as cyclobenzaprine
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A 3-Month Open-Label Safety and Efficacy Study of TNX-102 SL Tablets in Fibromyalgia PatientsNCT02589275 | Tonix Pharmaceuticals, Inc. | Phase 3 | Completed | 2016-09-28Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |